These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35390712)

  • 1. Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
    Liang JJ; Yu WL; Yang L; Qin KM; Yin YP; Li D; Ni YH; Yan JJ; Zhong YX; Deng ZX; Hong K
    Eur J Med Chem; 2022 Jun; 236():114313. PubMed ID: 35390712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of marine sesterterpene analogues as novel estrogen receptor α degraders for breast cancer treatment.
    Liang JJ; Yu WL; Yang L; Xie BH; Qin KM; Yin YP; Yan JJ; Gong S; Liu TY; Zhou HB; Hong K
    Eur J Med Chem; 2022 Feb; 229():114081. PubMed ID: 34992039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
    Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
    Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
    Wu Y; Zhao D; Shang J; Huang W; Chen Z
    Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
    Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
    Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y; Fan D
    Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
    Gao Z; Shi M; Wang Y; Chen J; Ou Y
    Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Thiazolidinone/Thiazolo[3,2-
    El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway.
    Xu X; Rajamanickam V; Shu S; Liu Z; Yan T; He J; Liu Z; Guo G; Liang G; Wang Y
    Drug Des Devel Ther; 2019; 13():3539-3550. PubMed ID: 31631978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Semi-Synthetic Cu (II)-Cardamonin Complex Exerts Potent Anticancer Activity against Triple-Negative Breast and Pancreatic Cancer Cells via Inhibition of the Akt Signaling Pathway.
    Hossan MS; Break MKB; Bradshaw TD; Collins HM; Wiart C; Khoo TJ; Alafnan A
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33918814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
    Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
    Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
    Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship studies of parthenolide derivatives as potential anti-triple negative breast cancer agents.
    Ge W; Hao X; Han F; Liu Z; Wang T; Wang M; Chen N; Ding Y; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Mar; 166():445-469. PubMed ID: 30739826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of melampomagnolide B derivatives as potential anti-Triple Negative Breast Cancer agents.
    Chen T; Chen X; Liu L; Zhang Q; Ding Y
    Eur J Med Chem; 2024 Jan; 264():116024. PubMed ID: 38104376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer.
    Hou Q; Lin X; Lu X; Bai C; Wei H; Luo G; Xiang H
    Bioorg Med Chem; 2020 Dec; 28(23):115763. PubMed ID: 32992255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Potent Oridonin Analogue for Treatment of Triple-Negative Breast Cancer.
    Yao H; Xie S; Ma X; Liu J; Wu H; Lin A; Yao H; Li D; Xu S; Yang DH; Chen ZS; Xu J
    J Med Chem; 2020 Aug; 63(15):8157-8178. PubMed ID: 32610904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloroform Fraction of Methanolic Extract of Seeds of Annona muricata Induce S Phase Arrest and ROS Dependent Caspase Activated Mitochondria-Mediated Apoptosis in Triple-Negative Breast Cancer.
    Kariyil BJ; Ayyappan UPT; Gopalakrishnan A; George AJ
    Anticancer Agents Med Chem; 2021; 21(10):1250-1265. PubMed ID: 32951586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
    Siraj MA; Jacobs AT; Tan GT
    Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
    Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.
    Zhao Y; Zhao C; Lu J; Wu J; Li C; Hu Z; Tian W; Yang L; Xiang J; Zhou H; Deng Z; Huang J; Hong K
    Pharmacol Res; 2019 Aug; 146():104294. PubMed ID: 31175940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.